Haemato AG

Haemato AG

HAEK · HM · Healthcare / Drug Manufacturers - Specialty & Generic

13.10EUR-0.40 (-2.96%)

Price History

Full chart

Market Stats

Previous Close13.50
Open12.80
Day Range12.80 – 13.80
52-Week Range8.17 – 13.56
Volume3.98K
Market Cap69.17M
P/E (TTM)5.78
Forward P/E0.00
EPS2.25
Dividend Yield0.31%
Beta-0.04
50-Day Avg12.93
200-Day Avg11.73

About

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG operates as a subsidiary of M1 Kliniken AG.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Thomas Ehmann
  • Employees76
  • HeadquartersLilienthalstrasse 3a, Schönefeld, Germany, 12529, Germany
  • Websitehttps://www.haemato.ag

Leadership

  • Mr. Thomas EhmannMD & Member of Management Board
  • Dr. Robin Wagner-FabischMD & Member of Management Board

Financials

Income Statement

Currency: EUR2021-12-312022-12-31
Total Revenue285.04M248.14M
Growth (%)--12.95%
Cost of Revenue254.31M226.53M
Gross Profit30.73M21.61M
Gross Margin10.78%8.71%
Operating Expense19.57M13.31M
Operating Income11.16M8.30M
Operating Margin3.92%3.34%
EBITDA11.25M12.21M
EBITDA Margin3.95%4.92%
Net Income6.53M8.19M
Net Income Margin2.29%3.30%
Interest Expense422.77K358.51K
Interest Expense % of Total Revenue0.15%0.14%

Balance Sheet

Currency: EUR2021-12-312022-12-31
Total Assets182.01M176.57M
Total Liabilities37.28M29.40M
Total Equity144.73M147.17M
Cash25.60M23.81M

Cash Flow

Currency: EUR2020-12-312021-12-312022-12-31
Operating Cash Flow-14.05M19.73M
Capital Expenditure0326.75K1.09M
Free Cash Flow-13.73M18.64M
Dividends Paid-2.76M5.75M
FCF to OCF-97.68%94.48%
Dividend Paid to FCF-20.11%30.85%

Key Statistics & Ratios

Market Cap69.17M
Enterprise Value37.87M
Trailing P/E5.78
Forward P/E0.00
Price / Sales0.27
Price / Book0.66
EPS2.25
Book Value28.59
Revenue (TTM)260.81M
Gross Profit (TTM)19.73M
EBITDA9.67M
Profit Margin3.68%
Operating Margin3.94%
Return on Equity6.52%
Return on Assets3.22%
Shares Outstanding5.23M
Shares Float5.20M
Beta-0.04
Dividend Yield0.31%
Dividend Rate0.04
Payout Ratio59.46%

Dividends

20261×
0.04Jul 8, 2026
20251×
0.04Jul 16, 2025
20241×
0.04Jul 17, 2024
20231×
1.20Jul 19, 2023
20221×
1.10Jul 13, 2022
20211×
1.00Jul 14, 2021
20191×
3.00Jul 11, 2019
20181×
3.00Jul 5, 2018
20171×
3.00Jun 23, 2017
20161×
3.00Jun 10, 2016
20151×
3.00Jun 10, 2015
20141×
3.00May 29, 2014
20131×
2.50May 31, 2013

Stock Splits

  • Sep 2, 20201:10